Tissue inhibitor of metalloproteinase-2 (TIMP-2)-deficient mice display motor deficits

Journal of Neurobiology

Volumn 66, Issue 1, 2006, Pages 82-94

  Jaworski, Diane M ^a   Soloway, Paul ^b   Caterina, John ^c   Falls, William A ^d  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b Department of Obstetrics Gynecology   (United States)

^c Bethel College   (United States)

^d UNIVERSITY OF VERMONT   (United States)

Author keywords

Cerebellum; Knock out; Muscle; Neuromuscular junction; TIMP

Indexed keywords

CHOLINERGIC RECEPTOR; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CONTROLLED STUDY; ENZYME DEGRADATION; ENZYME REGULATION; EXTRACELLULAR MATRIX; GAIT; GENE EXPRESSION; GRIP STRENGTH; HINDLIMB; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOUSE; NERVE FIBER GROWTH; NEUROMUSCULAR SYNAPSE; NONHUMAN; POSTNATAL DEVELOPMENT; POSTSYNAPTIC MEMBRANE; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURKINJE CELL; ROTAROD TEST; SKELETAL MUSCLE; SPINAL CORD MOTONEURON; TISSUE SPECIFICITY; WILD TYPE;

AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BLOTTING, NORTHERN; BLOTTING, WESTERN; BUNGAROTOXINS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CENTRAL NERVOUS SYSTEM; EMBRYO; GAIT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IMMUNOHISTOCHEMISTRY; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; MUSCLE DEVELOPMENT; MUSCLES; NEUROFILAMENT PROTEINS; NEUROMUSCULAR DISEASES; PHOSPHOPYRUVATE HYDRATASE; PSYCHOMOTOR PERFORMANCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; ROTAROD PERFORMANCE TEST; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 29244488777     PISSN: 00223034     EISSN: None     Source Type: Journal    
DOI: 10.1002/neu.20205     Document Type: Article

References (53)

1. Ahtikoski AM, Koskinen SO, Virtanen P, Kovanen V, Risteli J, Takala TE. 2003. Synthesis and degradation of type IV collagen in rat skeletal muscle during immobilization in shortened and lengthened positions. Acta Physiol Scand 177:473-481.
2. Ayoub AE, Cai TQ, Kaplan RA, Luo J. 2005. Developmental expression of matrix metalloproteinases 2 and 9 and their potential role in the histogenesis of the cerebellar cortex. J Comp Neurol 481:403-415.
3. Balice-Gordon RJ, Lichtman JW. 1993. In vivo observations of pre- and postsynaptic changes during synapse elimination at developing neuromuscular junctions in living mice. J Neurosci 13:834-855.
4. Brandon EP, Lin W, D'Amour KA, Pizzo DP, Dominguez B, Sugiura Y, Thode S, Ko CP, Thal LJ, Gage FH, et al. 2003. Aberrant patterning of neuromuscular synapses in choline acetyltransferase-deficient mice. J Neurosci 23: 539-549.
5. Brown MC, Jansen JKS, Van Essen D. 1976. Polyneuronal innervation of skeletal muscle in new-born rats and its elimination during maturation. J Physiol (Lond) 261:387-422.
6. Carmeli E, Moas M, Lennon S, Powers SK. 2005. High intensity exercise increases expression of matrix metalloproteinases in fast skeletal muscle fibers. Exp Physiol 90:613-619.
7. Carmeli E, Moas M, Reznick AZ, Coleman R. 2004. Matrix metalloproteinases and skeletal muscle: a brief review. Muscle Nerve 29:191-197.
8. Caterina JJ, Yamada S, Caterina NCM, Longenecker G, Holmbäck K, Shi J, Yermovsky AE, Engler JA, Birkedal-Hansen H. 2000. Inactivating mutation of the mouse Tissue Inhibitor of Metalloproteinases-2 (Timp-2) gene alters proMMP-2 activation. J Biol Chem 275:26416-26422.
9. Champaneria S, Swenarchuk LE, Anderson MJ. 1992. Increases in pericellular proteolysis at developing neuro-muscular junctions in culture. Dev Biol 149:261-277.
10. Connold AL, Evers JV, Vrbova G. 1986. Effect of low calcium and protease inhibitors on synapse elimination during postnatal development in the rat soleus muscle. Brain Res 393:99-107.
11. de Medinaceli L, Freed WJ, Wyatt RJ. 1982. An index of the functional condition of rat sciatic nerve based on measurements made from walking tracks. Exp Neurol 77: 634-643.
12. d'Ortho MP, Will H, Atkinson S, Butler G, Messent A, Gavrilovic J, Smith B, Timpl R, Zardi L, Murphy G. 1997. Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem 250: 751-757.
13. Dunham NW, Miya TS. 1957. A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharmacol Assoc 46:208-209.
14. English AW. 2003. Cytokines, growth factors and sprouting at the neuromuscular junction. J Neurocytol 32:943-960.
15. Fager N, Jaworski DM. 2000. Differential spatial distribution and temporal regulation of tissue inhibitor of metalloproteinase mRNA expression during rat central nervous system development. Mech Dev 98:105-109.
16. Gautam M, DeChiara TM, Glass DJ, Yancopoulos GD, Sanes JR. 1999. Distinct phenotypes of mutant mice lacking agrin, MuSK, or rapsyn. Dev Brain Res 114:171-178.
17. Haas TL, Milkiewicz M, Davis SJ, Zhou AL, Egginton S, Brown MD, Madri JA, Hudlicka O. 2000. Matrix metalloproteinase activity is required for activity-induced angiogenesis in rat skeletal muscle. Am J Physiol Heart Circ Physiol 279:H1540-1547.
18. Hammani K, Blakis A, Morsette D, Bowcock AM, Schmutte C, Henriet P, DeClerck YA. 1996. Structure and characterization of the human tissue inhibitor of metalloproteinase-2 gene. J Biol Chem 271:25498-25505.
19. Hayashita-Kinoh H, HKinoh H, Okada A, Komori K, Yoshifumi I, Chiba T, Kajita M, Yana I, Seiki M. 2001. Membrane-type 5 matrix metalloproteinase is expressed in differentiated neurons and regulates axonal growth. Cell Growth Differ 12:573-580.
20. Jaworski DM, Boone J, Caterina J, Soloway P, Falls WA. 2005. Prepulse inhibition and fear-potentiated startle are altered in Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) knockout mice. Brain Res 1051:81-89.
21. Jaworski DM, Fager N. 2000. Regulation of tissue inhibitor of metalloproteinase-3 (TIMP-3) mRNA expression during rat CNS development. J Neurosci Res 61:396-408.
22. Jaworski DM, Kelly GM, Hockfield S. 1994. BEHAB, a new member of the proteoglycan tandem repeat family of hyaluronan-binding proteins that is restricted to brain. J Cell Biol 125:495-509.
23. Jaworski DM, Kelly GM, Hockfield S. 1999. Intracranial injury acutely induces the expression of the secreted isoform of the CNS-specific hyaluronan-binding protein BEHAB/brevican. Exp Neurol 157:327-337.
24. Keller-Peck CR, Feng G, Sanes JR, Yan Q, Lichtman JW, Snider WD. 2001. Glial cell line-derived neurotrophic factor administration in postnatal life results in motor unit enlargement and continuous synaptic remodeling at the neuromuscular junction. J Neurosci 21:6136-6146.
25. Lenoir D, Battenberg E, Kiel M, Bloom FE, Milner RJ. 1986. The brain-specific gene 1B236 is expressed postnatally in the developing rat brain. J Neurosci 6:522-530.
26. Liu Y, Fields RD, Festoff BW, Nelson PG. 1994a. Proteolytic action of thrombin is required for electrical activity-dependent synapse reduction. Proc Natl Acad Sci USA 91:10300-10304.
27. Liu Y, Fields RD, Fitzgerald S, Festoff BW, Nelson PG. 1994b. Proteolytic activity, synapse elimination, and the Hebb synapse. J Neurobiol 25:325-335.
28. McCawley LJ, Matrisian LM. 2001. Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin Cell Biol 13:534-540.
29. Nagase H. 1997. Activation mechanisms of matrix metalloproteinases. Biol Chem 378:151-160.
30. Nagase H, Woessner JF. 1999. Matrix metalloproteinases. J Biol Chem 274:21491-21494.
31. Nguyen QT, Parsadanian AS, Snider WD, Lichtman JW. 1998. Hyperinnervation of neuromuscular junctions caused by GDNF overexpression in muscle. Science 279:1725-1729.
32. Nuttall RK, Sampieri CL, Pennington CJ, Gill SE, Schultz GA, Edwards DR. 2004. Expression analysis of the entire MMP and TIMP gene families during mouse tissue development. FEES Lett 563:129-134.
33. O'Brien RAD, Ostberg AJC, Vrbova G. 1984. Protease inhibitors reduce the loss of nerve terminals induced by activity and calcium in developing rat soleus muscles in vitro. Neuroscience 12:637-646.
34. Pérez-Martínez L, Jaworski DM. 2005. Tissue Inhibitor of Metalloproteinase-2 promotes neuronal differentiation by acting as an anti-mitogenic signal. J Neurosci 25:4917-4929.
35. Pranzatelli MR. 1990. Antimyoclonic effect of MK-801: a possible role for NMDA receptors in developmental myoclonus of the neonatal rat. Clin Neuropharmacol 13: 329-338.
36. Ratnikov BI, Rozanov DV, Postnova TI, Baciu PG, Zhang H, DiScipio RG, Chestukhina GG, Smith JW, Deryugina EI, Strongin AY. 2002. An alternative processing of integrin alpha(v) subunit in tumor cells by membrane type-1 matrix metalloproteinase. J Biol Chem 277:7377-7385.
37. Redfern PA. 1970. Neuromuscular transmission in newborn rats. J Physiol (Lond) 209:701-709.
38. Rogers DC, Fisher EM, Brown SD, Peters J, Hunter AJ, Martin JE. 1997. Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm Genome 8:711-713.
39. Sanes JR, Lichtman JW. 2001. Induction, assembly, maturation and maintenance of a postsynaptic apparatus. Nat Rev Neurosci 2:791-805.
40. Schwander M, Shirasaki R, Pfaff SL, Muller U. 2004. β1 integrins in muscle, but not in motor neurons, are required for skeletal muscle innervation. J Neurosci 24: 8181-8191.
41. Son YJ, Thompson WJ. 1995. Schwann cell processes guide regeneration of peripheral axons. Neuron 14:125-132.
42. Tam SL, Gordon T. 2003. Mechanisms controlling axonal sprouting at the neuromuscular junction. J Neurocytol 32:961-974.
43. Vaillant C, Didier-Bazès M, Hutter A, Belin M-F, Thomasset N. 1999. Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum. J Neurosci 19:4994-5004.
44. Vaillant C, Meissirel C, Mutin M, Belin MF, Lund LR, Thomasset N. 2003. MMP-9 deficiency affects axonal outgrowth, migration, and apoptosis in the developing cerebellum. Mol Cell Neurosci 24:395-408.
45. Van Gieson EJ, Skalak TC. 2001. Chronic vasodilation induces matrix metalloproteinase 9 (MMP-9) expression during microvascular remodeling in rat skeletal muscle. Microcirculation 8:25-31.
46. VanSaun M, Werle MJ. 2000. Matrix metalloproteinase-3 removes agrin from synaptic basal lamina. J Neurobiol 43:140-149.
47. Walsh MK, Lichtman JW. 2003. In vivo time-lapse imaging of synaptic takeover associated with naturally occurring synapse elimination. Neuron 37:67-73.
48. Wang Z, Juttermann R, Soloway PD. 2000. TIMP-2 is required for efficient activation of proMMP-2 in vivo. J Biol Chem 275:26411-26415.
49. Werle MJ, VanSaun M. 2003. Activity dependent removal of agrin from synaptic basal lamina by matrix metalloproteinase 3. J Neurocytol 32:905-913.
50. Yamada H, Saito F, Fukuta-Ohi H, Zhong D, Hase A, Arai K, Okuyama A, Maekawa R, Shimizu T, Matsumura K. 2001. Processing of β-dystroglycan by matrix metalloproteinase disrupts the link between the extracellular matrix and cell membrane via the dystroglycan complex. Hum Mol Genet 15:1563-1569.
51. Young DA, Phillips BW, Lundy C, Nuttall RK, Hogan A, Schultz GA, Leco KJ, Clark IM, Edwards DR. 2002. Identification of an initiator-like element essential for the expression of the tissue inhibitor of metalloproteinases-4 (Timp-4) gene. Biochem J 364:89-99.
52. Zimmerman SD, McCormick RJ, Vadlamudi RK, Thomas DP. 1993. Age and training alter collagen characteristics in fast- and slow-twitch rat limb muscle. J Appl Physiol 75: 1670-1674.
53. Zoubine MN, Ma JY, Smimova IV, Citron BA, Festoff BW. 1996. A molecular mechanism for synapse elimination: novel inhibition of locally generated thrombin delays synapse loss in neonatal mouse muscle. Dev Biol 179:447-457.